Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells. - Vincenzetti L; Wong R; Marzi R; Guarino B; Stefanutti E; Gupta SV; Rosen LE; Belnap DM; Wang L; Chen YP; di Iulio J; Momin A; et al. (Journal of hepatology, 2026)